Search - tctmd.com

Displaying 101 - 120 of 250

Sort: Relevancy | Date

News Daily News

‘J-Curve’ in Hypertension May Be Explained by Differences in Patient Characteristics

Todd Neale

September 26, 2017

News Daily News

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Yael L. Maxwell

August 24, 2017

News Daily News

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

Ashley Lyles

August 07, 2017

News Daily News

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

L.A. McKeown

July 20, 2017

News Daily News

No Racial Disparity in Post-PCI Mortality Seen at the VA

Todd Neale

July 19, 2017

News Daily News

Highs and Lows: Contrast Volume in PCI Varies Greatly Among US Physicians

Caitlin E. Cox

July 10, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

News Daily News

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Michael O'Riordan

March 16, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

News Daily News

Aspirate Contrast to Limit Acute Kidney Injury in Select Coronary Angiography Cases: Maybe, Maybe Not

Yael L. Maxwell

January 09, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Todd Neale

January 06, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Daily News

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

L.A. McKeown

December 13, 2016

News Daily News

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Shelley Wood

December 02, 2016

News Daily News

Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes

Shelley Wood

September 28, 2016

News Daily News

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Michael O'Riordan

September 15, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

Advertisement

‘J-Curve’ in Hypertension May Be Explained by Differences in Patient Characteristics

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

No Racial Disparity in Post-PCI Mortality Seen at the VA

Highs and Lows: Contrast Volume in PCI Varies Greatly Among US Physicians

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Aspirate Contrast to Limit Acute Kidney Injury in Select Coronary Angiography Cases: Maybe, Maybe Not

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content